Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 24.

Journal Article

Allo, Gabriel, Can, Ahu Damla, Wahba, Roger, Vogel, Nils, Goeser, Tobias, Kutting, Fabian and Waldschmidt, Dirk (2022). Nanoliposomal irinotecan in combination with leucovorin and 5-fluorouracil in advanced biliary tract cancers. Mol. Clin. Oncol., 16 (2). ATHENS: SPANDIDOS PUBL LTD. ISSN 2049-9469

Ben Khaled, Najib, Seidensticker, Max, Ricke, Jens, Mayerle, Julia, Oehrle, Bettina, Roessler, Daniel, Teupser, Daniel, Ehmer, Ursula, Bitzer, Michael ORCID: 0000-0002-4463-8263, Waldschmidt, Dirk, Fuchs, Martin, Reuken, Philipp A., Lange, Christian M., Wege, Henning, Kandulski, Arne, Dechene, Alexander, Venerito, Marino, Berres, Marie-Luise, Luedde, Tom ORCID: 0000-0002-6288-8821, Kubisch, Ilja, Reiter, Florian P. and De Toni, Enrico N. (2022). Atezolizumab and bevacizumab with transarterial chemoembolization in hepatocellular carcinoma: the DEMAND trial protocol. Future Oncol., 18 (12). S. 1423 - 1436. LONDON: FUTURE MEDICINE LTD. ISSN 1744-8301

Ceccon, Garry, Wollring, Michael, Brunn, Anna, Deckert, Martina, Waldschmidt, Dirk, Fink, Gereon R. ORCID: 0000-0002-8230-1856 and Galldiks, Norbert ORCID: 0000-0002-2485-1796 (2020). Leptomeningeal Carcinomatosis in a Patient with Pancreatic Cancer Responding to Nab-Paclitaxel plus Gemcitabine. Case Rep. Oncol., 13 (1). S. 35 - 43. BASEL: KARGER. ISSN 1662-6575

Damanakis, Alexander I., Ostertag, Luisa, Waldschmidt, Dirk, Kuetting, Fabian, Quaas, Alexander, Plum, Patrick, Bruns, Christiane J., Gebauer, Florian and Popp, Felix (2019). Proposal for a definition of Oligometastatic disease in pancreatic cancer. BMC Cancer, 19 (1). LONDON: BMC. ISSN 1471-2407

De Toni, Enrico N., Kubisch, Ilja, Ben Khaled, Najib, Ricke, Jens, Mayerle, Julia, Ehmer, Ursula, Waldschmidt, Dirk, Roessler, Daniel Christoph, Oehrle, Bettina, Bitzer, Michael, Kandulski, Arne, Reuken, Philipp A., Wege, Henning and Seidensticker, Max (2022). Atezolizumab and bevacizumab with transarterial chemoembolization in hepatocellular carcinoma: The DEMAND randomized phase II clinical trial. J. Clin. Oncol., 40 (4). PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1527-7755

El-Khoueiry, Anthony B., Kim, Richard D., Harris, William P., Sung, Max W., Waldschmidt, Dirk, Iqbal, Syma, Zhang, Xiaojing (Amily), Nakajima, Keiko and Galle, Peter R. (2020). Phase Ib study of regorafenib (REG) plus pembrolizumab (PEMBRO) for first-line treatment of advanced hepatocellular carcinoma (HCC). J. Clin. Oncol., 38 (4). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

El-Khoueiry, Anthony B., Kim, Richard D., Harris, William Proctor, Sung, Max W., Waldschmidt, Dirk, Cabrera, Roniel, Garosi, Vittorio Luigi, Zebger-Gong, Hong, Brennan, Barbara J., Wang, Ying A., Mueller, Udo, Ishida, Tatiane Cristine and Galle, Peter R. (2021). Updated results of a phase 1b study of regorafenib (REG) 80 mg/day or 120 mg/day plus pembrolizumab (PEMBRO) for first-line treatment of advanced hepatocellular carcinoma (HCC). J. Clin. Oncol., 39 (15). PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1527-7755

Faivre, Sandrine J., Santoro, Armando ORCID: 0000-0003-1709-9492, Kelley, Robin Kate, Merle, Philippe, Gane, Ed, Douillard, Jean-Yves, Waldschmidt, Dirk, Mulcahy, Mary Frances, Costentin, Charlotte, Minguez, Beatriz ORCID: 0000-0002-7276-9666, Papappicco, Pasqua, Gueorguieva, Ivelina, Cleverly, Ann, Desaiah, Durisala, Lahn, Michael M., Ameryckx, Sophie, Benhadji, Karim A., Raymond, Eric and Giannelli, Gianluigi (2014). A phase 2 study of a novel transforming growth factor-beta (TGF-beta 1) receptor I kinase inhibitor, LY2157299 monohydrate (LY), in patients with advanced hepatocellular carcinoma (HCC). J. Clin. Oncol., 32 (3). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Gebauer, Florian, Damanakis, Alexander Ioannis, Popp, Felix, Quaas, Alexander, Kutting, Fabian, Lutz, Katrin, Held, Swantje, Deuss, Burkhard, Goser, Tobias, Waldschmidt, Dirk and Bruns, Christiane (2021). Study protocol of an open-label, single arm phase II trial investigating the efficacy, safety and quality of life of neoadjuvant chemotherapy with liposomal irinotecan combined with Oxaliplatin and 5-fluorouracil/Folinic acid followed by curative surgical resection in patients with hepatic Oligometastatic adenocarcinoma of the pancreas (HOLIPANC). BMC Cancer, 21 (1). LONDON: BMC. ISSN 1471-2407

Grimminger, Peter Philipp, Stephens, Craig, Waldschmidt, Dirk, Astrow, Stephanie H., Steffen, Hans-Michael, Hsiang, Jack, Zeger, Gary, Hoelscher, Arnulf H. and Maus, Marlin K. H. (2014). C-kit mRNA expression in pancreatic adenocarcinoma and matched stromal tissue: Prognostic and therapeutic implications. J. Clin. Oncol., 32 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Hartlapp, Ingo, Alguel, Hana, Goekkurt, Eray, Siegler, Gabriele, Martens, Uwe, Waldschmidt, Dirk, Pelzer, Uwe ORCID: 0000-0001-9213-2737, Hennes, Elke, Fuchs, Martin, Siveke, Jens, Kullmann, Frank, Boeck, Stefan, Ettrich, Thomas J., Ferenczy, Peter, Keller, Ralph, Germer, Christoph-Thomas, Stein, Hubert, Klein, Ingo ORCID: 0000-0003-1097-0986, Heinemann, Volker and Kunzmann, Volker (2020). Induction Chemotherapy in Locally Advanced Pancreatic Cancer (LAPC) - Final Results of a Multicenter Randomized Phase 2 AIO Trial (NEOLAP). Oncol. Res. Treat., 43. S. 63 - 64. BASEL: KARGER. ISSN 2296-5262

Kruger, Stephan ORCID: 0000-0002-4138-9863, Boeck, Stefan, Heinemann, Volker, Laubender, Ruediger P., Vehling-Kaiser, Ursula, Waldschmidt, Dirk, Kettner, Erika, Maerten, Angela, Winkelmann, Cornelia, Klein, Stefan, Kojouharoff, Georgi, Gauler, Thomas C., Von Weikersthal, Ludwig Fischer, Clemens, Michael R., Geissler, Michael, Greten, Tim F., Hegewisch-Becker, Susanna, Modest, Dominik P., Stintzing, Sebastian ORCID: 0000-0002-3297-5801 and Haas, Michael (2015). Impact of hand-foot skin reaction on treatment outcome in patients receiving capecitabine plus erlotinib for advanced pancreatic cancer: A subgroup analysis from AIO-PK0104. Acta Oncol., 54 (7). S. 993 - 1001. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1651-226X

Kunzmann, Volker, Martens, Uwe Marc, Alguel, Hana, Siveke, Jens T., Goekkurt, Eray, Pelzer, Uwe ORCID: 0000-0001-9213-2737, Siegler, Gabriele Margareta, Hennes, Elke, Waldschmidt, Dirk, Jakobs, Ralf, Ferenczy, Peter, Keller, Ralph, Boeck, Stefan Hubert, Kullmann, Frank, Kapp, Markus and Germer, Christoph Thomas (2018). Secondary resectability in locally advanced pancreatic cancer (LAPC) after nab-paclitaxel/gemcitabine- versus FOLFIRINOX-based induction chemotherapy: Interim results of a randomized phase II AIO trial (NEOLAP). J. Clin. Oncol., 36 (4). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Kunzmann, Volker, Siveke, Jens T., Alguel, Hana, Goekkurt, Eray, Siegler, Gabriele, Martens, Uwe, Waldschmidt, Dirk, Pelzer, Uwe ORCID: 0000-0001-9213-2737, Fuchs, Martin, Kullmann, Frank, Boeck, Stefan, Ettrich, Thomas J., Held, Swantje, Keller, Ralph, Klein, Ingo, Germer, Christoph-Thomas, Stein, Hubert, Friess, Helmut, Bahra, Marcus, Jakobs, Ralf, Hartlapp, Ingo and Heinemann, Volker (2021). Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial. Lancet Gastroenterol. Hepatol., 6 (2). S. 128 - 139. SAN DIEGO: ELSEVIER INC. ISSN 2468-1253

Leuchte, Katharina, Staib, Elena, Thelen, Martin ORCID: 0000-0002-2785-9726, Goedel, Philipp, Lechner, Axel, Zentis, Peter, Garcia-Marquez, Maria, Waldschmidt, Dirk, Datta, Rabi Raj, Wahba, Roger, Wybranski, Christian, Zander, Thomas, Quaas, Alexander, Drebber, Uta, Stippel, Dirk Ludger, Bruns, Christiane, Von Bergwelt-Baildon, Michael, Wennhold, Kerstin and Schloesser, Hans Anton . Microwave ablation enhances tumor-specific immune response in patients with hepatocellular carcinoma. Cancer Immunol. Immunother.. NEW YORK: SPRINGER. ISSN 1432-0851

Loeser, Heike, Waldschmidt, Dirk, Kuetting, Fabian, Heydt, Carina, Zander, Thomas, Plum, Patrick, Alakus, Hakan, Buettner, Reinhard and Quaas, Alexander (2017). Copy-number variation and protein expression of DOT1L in pancreatic adenocarcinoma as a potential drug target. Mol. Clin. Oncol., 6 (5). S. 639 - 643. ATHENS: SPANDIDOS PUBL LTD. ISSN 2049-9469

Loeser, Heike, Waldschmidt, Dirk, Kuetting, Fabian, Schallenberg, Simon, Zander, Thomas, Bollschweiler, Elfriede, Hoelscher, Arnulf, Weckermann, Katharina, Plum, Patrick, Alakus, Hakan, Buettner, Reinhard and Quaas, Alexander (2017). Somatic BRCA1-associated protein 1 (BAP1) loss is an early and rare event in esophageal adenocarcinoma. Mol. Clin. Oncol., 7 (2). S. 225 - 229. ATHENS: SPANDIDOS PUBL LTD. ISSN 2049-9469

Makawita, Shalini, Kelley, Robin Kate, Roychowdhury, Sameek, Weiss, Karl Heinz, Abou-Alfa, Ghassan K., Macarulla, Teresa, Sadeghi, Saeed, Waldschmidt, Dirk, Zhu, Andrew X., Goyal, Lipika, Yong, Wei-Peng, Borbath, Ivan, El-Khoueiry, Anthony B., Philip, Philip Agop, Moran, Susan, Ye, Yining, Soifer, Harris S., Li, Gary, Berman, Craig and Javle, Milind M. (2020). Circulating free DNA (cfDNA) and tissue next-generation sequencing analysis in a phase II study of infigratinib (BGJ398) for cholangiocarcinoma with FGFR2 fusions. J. Clin. Oncol., 38 (4). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Maus, Martin K. H., Stephens, Craig, Waldschmidt, Dirk, Roll, Anika, Astrow, Stephanie H., Steffen, Hans-Michael, Hslang, Jack, Zeger, Gary, Hoelscher, Arnulf H. and Grimminger, Peter Philipp (2014). C-MET mRNA expression in pancreatic ductal adetiocarchaturia and stromal tissue: Prognostic and therapeutic implications. J. Clin. Oncol., 32 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Quaas, Alexander, Heydt, Carina, Waldschmidt, Dirk, Alakus, Hakan, Zander, Thomas, Goeser, Tobias, Kasper, Philipp, Bruns, Christiane, Brunn, Anna, Roth, Wilfried, Hartmann, Nils, Bunck, Anne, Schmidt, Matthias, Buettner, Reinhard and Merkelbach-Bruse, Sabine (2019). Alterations in ERBB2 and BRCA and microsatellite instability as new personalized treatment options in small bowel carcinoma. BMC Gastroenterol., 19. LONDON: BMC. ISSN 1471-230X

Sinn, Marianne, Bahra, Marcus, Liersch, Torsten, Gellert, Klaus, Messmann, Helmut, Bechstein, Wolf ORCID: 0000-0002-3267-8145, Waldschmidt, Dirk, Jacobasch, Lutz, Wilhelm, Martin, Rau, Bettina M., Gruetzmann, Robert, Weinmann, Arndt ORCID: 0000-0003-1198-1716, Maschmeyer, Georg, Pelzer, Uwe ORCID: 0000-0001-9213-2737, Stieler, Jens M., Striefler, Jana K., Ghadimi, Michael, Bischoff, Sven, Doerken, Bernd, Oettle, Helmut and Riess, Hanno (2017). CONKO-005: Adjuvant Chemotherapy With Gemcitabine Plus Erlotinib Versus Gemcitabine Alone in Patients After R0 Resection of Pancreatic Cancer: A Multicenter Randomized Phase III Trial. J. Clin. Oncol., 35 (29). S. 3330 - 3341. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Vehreschild, Maria J. G. T., Weitershagen, David, Biehl, Lena M., Tacke, Daniela, Waldschmidt, Dirk, Toex, Ulrich, Wisplinghoff, Hilmar, Bergwelt-Baildon, Michael V., Cornely, Oliver A. and Vehreschild, Joerg J. (2014). Clostridium Difficile Infection in Patients with Acute Myelogenous Leukemia and in Patients Undergoing Allogeneic Stem Cell Transplantation: Epidemiology and Risk Factor Analysis. Biol. Blood Marrow Transplant., 20 (6). S. 823 - 829. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1523-6536

Vogel, Arndt, Kasper, Stefan ORCID: 0000-0002-5947-8733, Bitzer, Michael, Block, Andreas, Sinn, Marianne, Schulze-Bergkamen, Henning, Moehler, Markus, Pfarr, Nicole, Endris, Volker, Goeppert, Benjamin ORCID: 0000-0002-4135-9250, Merx, Kirsten, Schnoy, Elisabeth, Siveke, Jens T., Michl, Patrick, Waldschmidt, Dirk, Kuhlmann, Jan, Geissler, Michael, Kahl, Christoph, Evenkamp, Ralph, Schmidt, Torben, Kuhlmann, Alexander, Weichert, Wilko and Kubicka, Stefan (2018). PICCA study: panitumumab in combination with cisplatin/gemcitabine chemotherapy in KRAS wild-type patients with biliary cancer-a randomised biomarker-driven clinical phase II AIO study. Eur. J. Cancer, 92. S. 11 - 20. OXFORD: ELSEVIER SCI LTD. ISSN 1879-0852

Westphalen, C. Benedikt, Heinemann, Volker, Tessen, Hans Werner, Groschek, Matthias, Hoeffkes, Heinz-Gert, Marschner, Norbert, Schulze, Mathias, Beringer, Andreas and Waldschmidt, Dirk (2020). Erlotinib plus Gemcitabine in metastatic pancreatic cancer: Results from a non-interventional trial. Z. Gastroent., 58 (4). S. 332 - 341. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1439-7803

This list was generated on Sun May 26 08:32:12 2024 CEST.